Narcolepsy/Cataplexy No statistical association was observed between GLP-1RA use and narcolepsy/cataplexy in time to event analysis
Its that we now have multiple real approaches peptide dual agonists, oral small molecules that can reach patients through different channels
Bradway also said Amgen is studying the efficacy of a range of different doses, adding that "we want to understand what will it take for patients to stay on this therapy, because persistence is the name of the game." Bradway also touched on Amgen's acquisition of Horizon Therapeutics, saying the deal is working well in part because it plays to his company's strengths biologics and autoimmunity
Plus, learn about the safety and side effects associated with salt substitutes, drug interactions, and more
[PubMed: 8843534] 118
Worldwide rates of obesity have jumped appreciably since the 1980s, and the 2023 World Obesity Atlas estimates that over half of the worlds population will be overweight or obese by 2035
